首页> 外文OA文献 >A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria

【2h】

A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria

机译：一项随机的II / III期研究，用于评估口服富乐草酸基因治疗原发性高草酸尿症的疗效和安全性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Milliner, Dawn; Hoppe, Bernd; Groothoff, Jaap;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria [J] . Milliner Dawn, Hoppe Bernd, Groothoff Jaap Urolithiasis. . 2018,第4期

机译：随机期II / III研究，评价口服施用的草酸杆菌的疗效和安全性治疗原发性高血脂尿素
2. Re: A Randomised Phase I/II Trial to Evaluate the Efficacy and Safety of Orally Administered Oxalobacter formigenes to Treat Primary Hyperoxaluria Editorial Comment [J] . Assimos Dean G. The Journal of Urology . 2017,第6期

机译：Re：随机阶段I / II试验，以评估口服给药的草酸杆菌的疗效和安全性治疗原发性高血症编辑评论
3. A randomised Phase I/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria [J] . Hoppe Bernd, Niaudet Patrick, Salomon Remi, Pediatric nephrology: journal of the International Pediatric Nephrology Association . 2017,第5期

机译：随机阶段I / II试验，以评估口服给药的草酸杆菌的疗效和安全性治疗原发性高血腺尿素
4. Field evaluation of the efficacy of enrofloxacin administered orally in a strategic medication of respiratory tract infections in finishing pigs [C] . P. Pommier, S. Wessel-Robert, B. Dellac, Congress of the International Pig Veterinary Society . 1999

机译：巢穴施用口服血红素施用疗效的实地评价在整理猪呼吸道感染的战略用药中
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria [O] . Dawn Milliner, Bernd Hoppe, Jaap Groothoff -1

机译：一项随机的II / III期研究用于评估口服富乐草酸基因治疗原发性高草酸尿症的疗效和安全性
7. Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer’s disease [O] . Lutz Frölich, Glen Wunderlich, Claus Thamer, 2019

机译：评估口服给药BI 409306的疗效，安全性和耐受性，一种新型磷酸二酯酶9抑制剂，在患有前一种随机的对照期II研究中，患者的前驱和轻度阿尔茨海默病患者疾病

A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria

著录项

引文网络

相似文献

相关主题

期刊订阅